The rapid delayed rectifier K+ current (Ikr) is critical for repolarization of the cardiac action potential. Previous studies have shown activated α1-adrenergic receptor (AR) attenuates β1-adrenergic regulation of Ikr while the mechanisms involved are poorly understood. To evalutate how α1-adrenergic receptor affect β1-adrenergic modulation of Ikr, whole-cell patch-clamp recordings were peformed in isolated guinea-pig ventricular myocytes. Application of xamoterol, a selective β1-AR agonist, induced a negative shift in the activation curve and Ikr current reduction by 40.50±6.66% at the test pulse of +40 mV. Forskolin and 8-Br-cAMP also resulted in Ikr reduction by 38.17±1.50% and 24.65±3.37%, respectively. Phenylephrine, a selective α1-AR agonist, prevented the activation shift and Ikr current reduction induced by xamoterol and forskolin, but not by 8-Br-cAMP. The effect of xamoterol or forskolin on Ikr was also prevented by pretreatment with PDBu, a protein kinase C (PKC) activator, while the effect of cAMP on Ikr can not, which was similar to pretreatment with phenylephrine. When cells were pretreated with chelerythrine, a specific PKC inhibitor, phenylephrine failed to prevent Ikr reduction induced by xamoterol. Our data suggests that α1-adrenergic stimulation attenuates β1-adrenergic regulation of Ikr, through PKC-dependent downregulation of adenylyl cyclase/cyclic AMP pathway.
Published in | International Journal of Clinical and Experimental Medical Sciences (Volume 5, Issue 2) |
DOI | 10.11648/j.ijcems.20190502.11 |
Page(s) | 26-32 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2019. Published by Science Publishing Group |
Adrenergic Receptors, Ikr, Cross-talk, Protein Kinase C, Adenylyl Cyclase
[1] | Sanguinetti MC, Jiang C, Curran ME and Keating MT A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel Cell Vol81, No2, 1995, pp 299-307. |
[2] | Trudeau MC, Warmke JW, Ganetzky B and Robertson GA HERG, a human inward rectifier in the voltage-gated potassium channel family Science Vol269, No5220, 1995, pp 92-95. |
[3] | Sanguinetti MC and Tristani-Firouzi M hERG potassium channels and cardiac arrhythmia Nature Vol 440, No 7083, 2006, pp 463-469. |
[4] | Ficker E, Thomas D, Viswanathan PC, Dennis AT, Priori SG, Napolitano C, Memmi M, Wible BA, Kaufman ES, Iyengar S, Schwartz PJ, Rudy Y and Brown AM Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome Am J Physiol Vol 279, No 4, 2000, pp H1748–H1756. |
[5] | Thomas D, Kiehn J, Katus HA and Karle CA Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): Molecular mechanisms and restoration of intracellular protein processing Cardiovasc Res Vol 60, No 2, 2003, pp 239–245. |
[6] | Thomas D, Karle CA and Kiehn J The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications Curr Pharm Des Vol 12, No 8, 2006, pp 2271-2283. |
[7] | Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y and Hill AP hERG K (+) channels: structure, function, and clinical significance Physiol Rev Vol 92, No 3, 2012, pp 1393-1478. |
[8] | Chae YJ, Lee HJ, Jeon JH, Kim IB, Choi JS, Sung KW and Hahn SJ Effects of donepezil on hERG potassium channels Brain Res Vol 1597, 2015, pp 77-85. |
[9] | Li G, Shi R, Wu J, Han W, Zhang A, Cheng G, Xue X and Sun C Association of the hERG mutation with long‑QT syndrome type 2, syncope and epilepsy Mol Med Rep Vol 13, No 3, 2016, pp 2467-2475. |
[10] | Zhang YH, Cheng H, Alexeenko VA, Dempsey CE, Hancox JC Characterization of recombinant hERG K+ channel inhibition by the active metabolite of amiodarone desethyl-amiodarone J Electrocardiol Vol 43, No5, 2010, pp 440-8. |
[11] | Brodde OE and Michel MC Adrenergic and muscarinic receptors in the human heart Pharmacol Rev Vol 51, No 4, 1999, pp 651–689. |
[12] | Karle CA, Zitron E, Zhang, W, Kathofer S, Schoels W and Kiehn J Rapid component IKr of the guinea-pig cardiac delayed rectifier K+ current is inhibited by β1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways Cardiovasc Res Vol 53, No 2, 2002, pp 355–362. |
[13] | Thomas D, Zhang W, Karle CA, Kathofer S, Schols W, Kubler W and Kiehn J Deletion of protein kinase A phosphorylation sites in the hERG potassium channel inhibits activation shift by protein kinase A J Biol Chem Vol 274, No 39, 1999, pp27457–27462. |
[14] | Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H and Horie M Adrenergic regulation of the rapid component of delayed rectifier K+ current: Implications for arrhythmogenesis in LQT2 patients Heart Rhythm Vol 6, No 7, 2009, pp 1038–1046. |
[15] | Thomas D, Wu K, Wimmer AB, Zitron E, Hammerling BC, Kathofer S, Lueck S, Bloehs R, Kreye VA and Kiehn J Activation of cardiac human ether-a-go-go related gene potassium currents is regulated by α1A-adrenoceptors J Mol Med Vol 82, No 12, 2004, pp 826–837. |
[16] | Urrutia J, Alday A, Gallego M, Malagueta-Vieira LL, Aréchiga-Figueroa IA, Casis O and Sánchez-Chapula JA Mechanisms of IhERG/IKr Modulation by α1-Adrenoceptors in HEK293 Cells and Cardiac Myocytes Cell Physiol Biochem Vol 40, No 6, 2016, pp 1261-1273. |
[17] | Thomas D, Kiehn J, Katus HA and Karle CA Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I (Kr), and the underlying hERG ion channel Basic Res Cardiol Vol 99, No 4, 2004, pp 279–287. |
[18] | Wang S, Xu DJ, Cai JB, Huang YZ, Zou JG and Cao KJ Rapid component IKr of cardiac delayed rectifier potassium currents in guinea-pig is inhibited by α1-adrenoreceptor activation via protein kinase A and protein kinase C-dependent pathways Eur J Pharmacol Vol 608, No 1-3, 2009, pp 1-6. |
[19] | Xu D, Wang S, Wu TT, Wang XY, Qian J and Guo Y Functional cross-talk between the α1- and β1-adrenergic receptors modulates the rapidly activating delayed rectifier potassium current in guinea pig ventricular myocytes Int J Mol Sci Vol 15, No 9, 2014, pp 14220-14233. |
[20] | Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR and Kass RS Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel Science Vol 295, No 5554, 2002, pp 496-499. |
[21] | Harmati G, Bányász T, Bárándi L, Szentandrássy N, Horváth B, Szabó G, Szentmiklósi JA, Szénási G, Nánási PP and Magyar J Effects of β-adrenoceptor stimulation on delayed rectifier K (+) currents in canine ventricular cardiomyocytes Br J Pharmacol Vol 162, No 4, 2011, pp 890-896. |
[22] | Li GR, Feng J, Wang Z and Fermini, B Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes Circ Res Vol 78, No 5, 1996, pp 903-915. |
[23] | Koumi S, Backer CL, Arentzen CE and Sato R Beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricularmyocytes Alteration in channel response to beta-adrenergic stimulation in failing human hearts J Clin Invest Vol 96, No 6, 1995, pp 2870-2881. |
[24] | Gallego M, Alday A, Alonso H and Casis O Adrenergic regulation of cardiac ionic channels: role of membrane microdomains in the regulation of kv4 channels Biochim Biophys Acta Vol 1838, No 2, 2014, pp 692-699. |
[25] | Gallego M, Setién R, Puebla L, Boyano-Adánez MC, Arilla E and Casis O alpha1-Adrenoceptors stimulate a Galphas protein and reduce the transient outward K+ current via a cAMP/PKA-mediated pathway in the rat heart Am J Physiol Cell Physiol Vol 288, No 3, 2005, pp C577–C585 |
[26] | Wu TT, Wang S, Zou JG, Cao KJ and Xu D Cross effect of acute adrenergic stimulation on rapid component of delayed rectifier potassium channel current in guinea pig left ventriculare myocytes Chin J Cardiac Arrhyth Vol 2, 2014, pp 146-152. |
[27] | Middleton LM and Harvey RD PKC regulation of cardiac CFTR Cl- channel function in guinea pig ventricular myocytes Am J Physiol Vol275, No 1, 1998, pp C293-C302. |
[28] | Li L, Cai H, Liu H and Guo T β-Adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy Mol Med Rep Vol 11, No, 2015, pp 4373-4380. |
[29] | Yue Y, Qu Y and Boutjdir M Beta- and alpha-adrenergic cross-signaling for L-type Ca current is impaired in transgenic mice with constitutive activation of epsilonPKC Biochem Biophys Res Commun Vol 314, No 3, 2004, pp 749-754. |
[30] | Guimond J, Mamarbachi AM, Allen BG, Rindt H and Hébert TE Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors Cell Signal Vol 17, No 1, 2005, pp 49-58. |
[31] | Lai HL, Yang TH, Messing RO, Ching YH, Lin SC and Chern Y Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response Journal of Biological Chemistry Vol 272, No 8, 1997, pp 4970-4977. |
[32] | Boutjdir M, Restivo M, Wei Y and el-Sherif N Alpha1- and beta-adrenergic interactions on L-type calcium current in cardiac myocytes Pfluigers Archiv Vol 421, No 4, 1992, pp 397-399. |
[33] | Barrett S, Honbo N and Karliner JS Alpha1-adrenoceptor-mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes Naunyn Schmiedebergs Arch Pharmacol Vol 347, No, 1993, pp 384-393. |
[34] | Pollard CE, Abi Gerges N, Bridgland-Taylor MH, Easter A, Hammond TG and Valentin JP An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk Br J Pharmacol 2010; Vol 159, No, 2010, pp 12-21. |
[35] | Rain C and Rada G Is carvedilol better than other beta-blockers for heart failure? Medwave 2015; 15 Suppl 1: e6168. |
APA Style
Sen Wang, Xiaoyan Wang, Jin Qian, Di Xu. (2019). α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes. International Journal of Clinical and Experimental Medical Sciences, 5(2), 26-32. https://doi.org/10.11648/j.ijcems.20190502.11
ACS Style
Sen Wang; Xiaoyan Wang; Jin Qian; Di Xu. α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes. Int. J. Clin. Exp. Med. Sci. 2019, 5(2), 26-32. doi: 10.11648/j.ijcems.20190502.11
AMA Style
Sen Wang, Xiaoyan Wang, Jin Qian, Di Xu. α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes. Int J Clin Exp Med Sci. 2019;5(2):26-32. doi: 10.11648/j.ijcems.20190502.11
@article{10.11648/j.ijcems.20190502.11, author = {Sen Wang and Xiaoyan Wang and Jin Qian and Di Xu}, title = {α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes}, journal = {International Journal of Clinical and Experimental Medical Sciences}, volume = {5}, number = {2}, pages = {26-32}, doi = {10.11648/j.ijcems.20190502.11}, url = {https://doi.org/10.11648/j.ijcems.20190502.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20190502.11}, abstract = {The rapid delayed rectifier K+ current (Ikr) is critical for repolarization of the cardiac action potential. Previous studies have shown activated α1-adrenergic receptor (AR) attenuates β1-adrenergic regulation of Ikr while the mechanisms involved are poorly understood. To evalutate how α1-adrenergic receptor affect β1-adrenergic modulation of Ikr, whole-cell patch-clamp recordings were peformed in isolated guinea-pig ventricular myocytes. Application of xamoterol, a selective β1-AR agonist, induced a negative shift in the activation curve and Ikr current reduction by 40.50±6.66% at the test pulse of +40 mV. Forskolin and 8-Br-cAMP also resulted in Ikr reduction by 38.17±1.50% and 24.65±3.37%, respectively. Phenylephrine, a selective α1-AR agonist, prevented the activation shift and Ikr current reduction induced by xamoterol and forskolin, but not by 8-Br-cAMP. The effect of xamoterol or forskolin on Ikr was also prevented by pretreatment with PDBu, a protein kinase C (PKC) activator, while the effect of cAMP on Ikr can not, which was similar to pretreatment with phenylephrine. When cells were pretreated with chelerythrine, a specific PKC inhibitor, phenylephrine failed to prevent Ikr reduction induced by xamoterol. Our data suggests that α1-adrenergic stimulation attenuates β1-adrenergic regulation of Ikr, through PKC-dependent downregulation of adenylyl cyclase/cyclic AMP pathway.}, year = {2019} }
TY - JOUR T1 - α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes AU - Sen Wang AU - Xiaoyan Wang AU - Jin Qian AU - Di Xu Y1 - 2019/06/25 PY - 2019 N1 - https://doi.org/10.11648/j.ijcems.20190502.11 DO - 10.11648/j.ijcems.20190502.11 T2 - International Journal of Clinical and Experimental Medical Sciences JF - International Journal of Clinical and Experimental Medical Sciences JO - International Journal of Clinical and Experimental Medical Sciences SP - 26 EP - 32 PB - Science Publishing Group SN - 2469-8032 UR - https://doi.org/10.11648/j.ijcems.20190502.11 AB - The rapid delayed rectifier K+ current (Ikr) is critical for repolarization of the cardiac action potential. Previous studies have shown activated α1-adrenergic receptor (AR) attenuates β1-adrenergic regulation of Ikr while the mechanisms involved are poorly understood. To evalutate how α1-adrenergic receptor affect β1-adrenergic modulation of Ikr, whole-cell patch-clamp recordings were peformed in isolated guinea-pig ventricular myocytes. Application of xamoterol, a selective β1-AR agonist, induced a negative shift in the activation curve and Ikr current reduction by 40.50±6.66% at the test pulse of +40 mV. Forskolin and 8-Br-cAMP also resulted in Ikr reduction by 38.17±1.50% and 24.65±3.37%, respectively. Phenylephrine, a selective α1-AR agonist, prevented the activation shift and Ikr current reduction induced by xamoterol and forskolin, but not by 8-Br-cAMP. The effect of xamoterol or forskolin on Ikr was also prevented by pretreatment with PDBu, a protein kinase C (PKC) activator, while the effect of cAMP on Ikr can not, which was similar to pretreatment with phenylephrine. When cells were pretreated with chelerythrine, a specific PKC inhibitor, phenylephrine failed to prevent Ikr reduction induced by xamoterol. Our data suggests that α1-adrenergic stimulation attenuates β1-adrenergic regulation of Ikr, through PKC-dependent downregulation of adenylyl cyclase/cyclic AMP pathway. VL - 5 IS - 2 ER -